$TCMD
TACTILE SYSTEMS TECHNOLOGY INC Stock $tcmd

$tcmd Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000155837022011459 Filed on August 01, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$65.26M	$59.65M	$47.98M
YoY Change	24.32%	16.81%	12.17%
Cost Of Revenue	$18.47M	$16.42M	$14.12M
YoY Change	18.93%	10.55%	12.55%
Gross Profit	$46.79M	$43.22M	$33.86M
YoY Change	26.58%	19.38%	12.01%
Gross Profit Margin	71.7%	72.47%	70.58%
Selling, General & Admin	$42.84M	$43.72M	$40.15M
YoY Change	16.63%	24.81%	21.68%
% of Gross Profit	91.55%	101.14%	118.56%
Research & Development	$1.581M	$1.849M	$1.520M
YoY Change	12.21%	53.32%	19.69%
% of Gross Profit	3.38%	4.28%	4.49%
Depreciation & Amortization	$1.655M	$1.508M	$1.507M
YoY Change	91.77%	136.73%	131.13%
% of Gross Profit	3.54%	3.49%	4.45%
Operating Expenses	$48.41M	$47.31M	$48.76M
YoY Change	26.29%	30.4%	42.11%
Operating Profit	-$1.620M	-$4.087M	-$14.90M
YoY Change	18.51%	5277.63%	264.86%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$736.0K	-$573.0K	-$456.0K
YoY Change	513.33%	2287.5%	4460.0%
Pretax Income	-$2.356M	-$4.660M	-$15.36M
YoY Change	58.44%	4560.0%	275.11%
Income Tax	-$77.00K	-$20.00K	$200.0K
% Of Pretax Income
Net Earnings	-$2.279M	-$4.640M	-$15.57M
YoY Change	-32.07%	-455.56%	587.03%
Net Earnings / Revenue	-3.49%	-7.78%	-32.45%
Basic Earnings Per Share	-$0.11	-$0.23	-$0.78
Diluted Earnings Per Share	-$0.11	-$0.23	-$0.78
COMMON SHARES
Basic Shares Outstanding	20.13M	20.02M	19.90M
Diluted Shares Outstanding	20.14M	20.02M	19.90M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$38.48M	$36.70M	$33.46M
YoY Change	71.77%	-25.12%	-28.7%
Cash & Equivalents	$23.43M	$23.35M	$21.15M
Short-Term Investments	$15.05M	$13.35M	$12.31M
Other Short-Term Assets	$3.484M	$1.446M	$4.374M
YoY Change	-5.86%	-30.88%	98.82%
Inventory	$23.02M	$19.97M	$19.48M
Prepaid Expenses
Receivables	$51.81M	$49.16M	$45.93M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$116.8M	$107.3M	$103.2M
YoY Change	9.59%	-15.28%	-15.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.677M	$5.978M	$6.330M
YoY Change	3.39%	-6.58%	-6.17%
Goodwill	$31.06M	$31.06M	$31.06M
YoY Change	0.0%
Intangibles	$51.31M	$52.25M	$53.17M
YoY Change	-4.1%	2970.15%	3059.18%
Long-Term Investments
YoY Change
Other Assets	$3.004M	$2.768M	$2.321M
YoY Change	44.28%	30.69%	14.33%
Total Long-Term Assets	$131.7M	$130.0M	$129.8M
YoY Change	-7.77%	136.38%	145.89%
TOTAL ASSETS
Total Short-Term Assets	$116.8M	$107.3M	$103.2M
Total Long-Term Assets	$131.7M	$130.0M	$129.8M
Total Assets	$248.5M	$237.3M	$233.0M
YoY Change	-0.35%	30.65%	32.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.17M	$9.110M	$6.200M
YoY Change	80.41%	80.04%	-33.7%
Accrued Expenses	$6.953M	$5.258M	$5.673M
YoY Change	29.96%	31.12%	75.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.968M	$2.968M	$2.964M
YoY Change	34.3%
Total Short-Term Liabilities	$55.66M	$46.55M	$40.27M
YoY Change	77.78%	74.7%	43.91%
LONG-TERM LIABILITIES
Long-Term Debt	$46.63M	$47.35M	$48.08M
YoY Change	-11.22%
Other Long-Term Liabilities	$31.79M	$29.16M	$29.54M
YoY Change	-4.99%	30.93%	33.05%
Total Long-Term Liabilities	$78.47M	$76.64M	$77.76M
YoY Change	-8.74%	244.1%	250.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$55.66M	$46.55M	$40.27M
Total Long-Term Liabilities	$78.47M	$76.64M	$77.76M
Total Liabilities	$134.1M	$123.2M	$118.0M
YoY Change	14.36%	151.83%	135.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.24M	-$11.96M	-$7.323M
YoY Change	-190.48%	-162.65%	-141.16%
Common Stock	$20.00K	$20.00K	$20.00K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$114.4M	$114.1M	$115.0M
YoY Change
Total Liabilities & Shareholders Equity	$248.5M	$237.3M	$233.0M
YoY Change	-0.35%	30.65%	32.94%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.279M	-$4.640M	-$15.57M
YoY Change	-32.07%	-455.56%	587.03%
Depreciation, Depletion And Amortization	$1.655M	$1.508M	$1.507M
YoY Change	91.77%	136.73%	131.13%
Cash From Operating Activities	$2.254M	$2.306M	-$3.206M
YoY Change	-313.04%	-306.45%	300.75%
INVESTING ACTIVITIES
Capital Expenditures	-$1.428M	-$241.0K	$131.0K
YoY Change	114.74%	-44.34%	-47.39%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.428M	-$241.0K	-$175.0K
YoY Change	-98.23%	-44.34%	-43.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-750.0K	135.0K	-3.698M
YoY Change	-101.36%	-96.28%	-2143.09%
NET CHANGE
Cash From Operating Activities	2.254M	2.306M	-3.206M
Cash From Investing Activities	-1.428M	-241.0K	-175.0K
Cash From Financing Activities	-750.0K	135.0K	-3.698M
Net Change In Cash	76.00K	2.200M	-7.079M
YoY Change	-100.29%	5.67%	661.18%
FREE CASH FLOW
Cash From Operating Activities	$2.254M	$2.306M	-$3.206M
Capital Expenditures	-$1.428M	-$241.0K	$131.0K
Free Cash Flow	$3.682M	$2.547M	-$3.337M
YoY Change	-1036.9%	-472.37%	218.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37799
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseRightOfUseAsset
CY2022Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityCurrent
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent
	dei	Entity Central Index Key EntityCentralIndexKey	0001027838
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20132145
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19877786
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseRightOfUseAsset
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityCurrent
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Registrant Name EntityRegistrantName	Tactile Systems Technology, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3701 Wayzata Blvd, Suite 300
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1801204
	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55416
CY2021Q2	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	7430000
CY2022Q2	us-gaap	Inventory Net InventoryNet	19970000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3015000
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1287000
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-94000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18988000
CY2021Q4	us-gaap	Inventory Net InventoryNet	19217000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1446000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4141000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4160000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	107269000
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	3581000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	113547000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5978000
CY2021Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	3108000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6750000
CY2022Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	298000
CY2021Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	348000
	us-gaap	Share Based Compensation ShareBasedCompensation	5121000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22628000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23984000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52254000
	us-gaap	Share Based Compensation ShareBasedCompensation	5115000
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-7550000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22122000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23354000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	126000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	54081000
CY2022Q2	us-gaap	Goodwill Goodwill	31063000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	32000
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	76641000
CY2021Q4	us-gaap	Goodwill Goodwill	31063000
CY2022Q2	tcmd	Medicare Accounts Receivable Non Current MedicareAccountsReceivableNonCurrent	15343000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-321000
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-573000
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	81582000
	dei	City Area Code CityAreaCode	612
	dei	Local Phone Number LocalPhoneNumber	355-5100
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	TCMD
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q2	us-gaap	Liabilities Liabilities	123187000
CY2021Q4	us-gaap	Liabilities Liabilities	116043000
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20132081
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23350000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28229000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	49157000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	49478000
CY2022Q2	us-gaap	Net Investment In Lease NetInvestmentInLease	13346000
CY2021Q4	us-gaap	Net Investment In Lease NetInvestmentInLease	12482000
CY2021Q4	tcmd	Medicare Accounts Receivable Non Current MedicareAccountsReceivableNonCurrent	12847000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2768000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1998000
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	130034000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20132145
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19877786
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	130723000
CY2022Q2	us-gaap	Assets Assets	237303000
CY2021Q4	us-gaap	Assets Assets	244270000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	9110000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5023000
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	2968000
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2960000
CY2022Q2	tcmd	Earn Out Current EarnOutCurrent	9800000
CY2021Q4	tcmd	Earn Out Current EarnOutCurrent	3250000
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12144000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12139000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5258000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5262000
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	11000
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	16000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2488000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2506000
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4767000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3305000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	46546000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	34461000
CY2022Q2	us-gaap	Line Of Credit LineOfCredit	24891000
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	24857000
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	22463000
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	26933000
CY2022Q2	tcmd	Earn Out Non Current EarnOutNonCurrent	3950000
CY2021Q4	tcmd	Earn Out Non Current EarnOutNonCurrent	2950000
CY2022Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	2791000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	36281000
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	20000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	20000
	us-gaap	Operating Expenses OperatingExpenses	96073000
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	126059000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	114116000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	128227000
	us-gaap	Operating Expenses OperatingExpenses	70595000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20017000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4087000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-76000
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4194000
	tcmd	Amortization Of Intangible Assets And Earn Outs AmortizationOfIntangibleAssetsAndEarnOuts	8841000
	tcmd	Amortization Of Intangible Assets And Earn Outs AmortizationOfIntangibleAssetsAndEarnOuts	98000
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	47310000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	119962000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11963000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8245000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	237303000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	244270000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59645000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51060000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	107623000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	93832000
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	16422000
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	14855000
	us-gaap	Cost Of Revenue CostOfRevenue	30538000
	us-gaap	Cost Of Revenue CostOfRevenue	27397000
CY2022Q2	us-gaap	Gross Profit GrossProfit	43223000
CY2021Q2	us-gaap	Gross Profit GrossProfit	36205000
	us-gaap	Gross Profit GrossProfit	77085000
	us-gaap	Gross Profit GrossProfit	66435000
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28822000
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20933000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	52752000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	39718000
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1849000
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1206000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3369000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2476000
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14894000
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14094000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31111000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	28303000
CY2022Q2	tcmd	Amortization Of Intangible Assets And Earn Outs AmortizationOfIntangibleAssetsAndEarnOuts	1745000
CY2021Q2	tcmd	Amortization Of Intangible Assets And Earn Outs AmortizationOfIntangibleAssetsAndEarnOuts	48000
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1029000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-34000
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4660000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-100000
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4640000
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1305000
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-20000
	us-gaap	Profit Loss ProfitLoss	-20208000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1405000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	191000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3233000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20208000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-961000
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.23
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.07
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.01
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.05
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.23
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.07
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.01
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.05
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20024798
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19691156
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19961999
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19618759
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20024798
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20047277
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19961999
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19618759
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	114978000
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2892000
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	62000
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	824000
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4640000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	114116000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	128227000
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	5121000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	152000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	824000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20208000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	114116000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	125122000
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2658000
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2089000
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1542000
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1305000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	132716000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	124750000
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	5115000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3385000
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-1115000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1542000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-961000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	132716000
	us-gaap	Profit Loss ProfitLoss	-961000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	753000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2590000
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Note 1. Nature of Business and Operations</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Tactile Systems Technology, Inc. (“we,” “us,” and “our”) manufactures and distributes medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition.</span> <span style="font-family:'Arial','Helvetica','sans-serif';">We provide our Flexitouch® and Entre™ systems through our direct sales force for use in the home and sell or rent them through vascular, wound and lymphedema clinics throughout the United States. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">On September 8, 2021, we acquired the assets of the AffloVest airway clearance business (“AffloVest Acquisition”) from International Biophysics Corporation (“IBC”), a privately-held company which developed and manufactures AffloVest. AffloVest is a portable, wearable vest that treats patients with chronic respiratory conditions. We sell this device through home medical equipment and durable medical equipment (“DME”) providers throughout the United States. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">We were originally incorporated in Minnesota under the name Tactile Systems Technology, Inc. on January 30, 1995. During 2006, we established a merger corporation and subsequently, on July 21, 2006, merged with and into this merger corporation, resulting in our reincorporation as a Delaware corporation. The resulting corporation assumed the name Tactile Systems Technology, Inc. In September 2013, we began doing business as “Tactile Medical”.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Our business is affected by seasonality. In the first quarter of each year, when most patients have started a new insurance year and have not yet met their annual out-of-pocket payment obligations, we experience substantially reduced demand for our products. We typically experience higher revenue in the third and fourth quarters of the year when patients have met their annual insurance deductibles, thereby reducing their out-of-pocket costs for our products, and because patients desire to exhaust their flexible spending accounts at year end. This seasonality applies only to purchases and rentals of our products by patients covered by commercial insurance and is not relevant to Medicare, Medicaid or the Veterans Administration, as those payers either do not have plans that have declining deductibles over the course of the plan year and/or do not have plans that include patient deductibles for purchases or rentals of our products. </span><span style="font-family:'Arial','Helvetica','sans-serif';">Further, seasonality trends have been, and may continue to be, significantly different than historical trends as a result of the COVID-19 pandemic and related impacts</span><span style="font-family:'Arial','Helvetica','sans-serif';">.</span></p>
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2488000
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	55000
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	12252000
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	10975000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1220000
	tcmd	Increase Decrease In Net Investment In Lease IncreaseDecreaseInNetInvestmentInLease	864000
	tcmd	Increase Decrease In Net Investment In Lease IncreaseDecreaseInNetInvestmentInLease	1033000
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	780000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1925000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-502000
	tcmd	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-106000
	tcmd	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-99000
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	2496000
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	2441000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4087000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	855000
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	5000
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1285000
	tcmd	Increase Decrease In Other Accrued Liabilities And Income Taxes Payable IncreaseDecreaseInOtherAccruedLiabilitiesAndIncomeTaxesPayable	1252000
	tcmd	Increase Decrease In Other Accrued Liabilities And Income Taxes Payable IncreaseDecreaseInOtherAccruedLiabilitiesAndIncomeTaxesPayable	1676000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-900000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1917000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	331000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	603000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	85000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	140000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-416000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-743000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4500000
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	39000
	tcmd	Payment Of Taxes For Net Share Settlement Of Restricted Stock Units PaymentOfTaxesForNetShareSettlementOfRestrictedStockUnits	1115000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	152000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3385000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	824000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1542000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3563000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3812000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4879000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1152000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28229000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47855000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23350000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49007000
	us-gaap	Interest Paid Net InterestPaidNet	448000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	28000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1141000
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	8000
CY2022Q2	us-gaap	Inventory Net InventoryNet	19970000
CY2021Q4	us-gaap	Inventory Net InventoryNet	19217000
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1900000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	45973000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3812000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	42161000
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	56066000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3812000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52254000
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4995000
CY2021Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4869000
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4818000
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:14pt 0pt 0pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:14pt 0pt 0pt 0pt;"><span style="color:#2b2c2b;font-family:'Arial','Helvetica','sans-serif';">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and to disclose contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	5117000
CY2021Q3	tcmd	Line Of Credit Threshold Contingent Increase In Borrowing Capacity LineOfCreditThresholdContingentIncreaseInBorrowingCapacity	25000000.0
CY2021Q3	tcmd	Credit Agreement Total Aggregate Principal Amount CreditAgreementTotalAggregatePrincipalAmount	80000000.0
CY2021Q3	us-gaap	Line Of Credit LineOfCredit	25000000.0
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	45916000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1900000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44016000
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	55981000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1900000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	54081000
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000.0
CY2021Q3	tcmd	Goodwill Amortization Period For Tax Purposes GoodwillAmortizationPeriodForTaxPurposes	P15Y
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	53500000
CY2021Q3	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P12Y3M18D
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22628000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23984000
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7718000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8242000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1913000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3795000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3773000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3683000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3619000
CY2022Q2	tcmd	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	25378000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	42161000
CY2022Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2027000
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1851000
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	714000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	661000
CY2022Q2	tcmd	Accrued Travel And Entertainment Current AccruedTravelAndEntertainmentCurrent	611000
CY2021Q4	tcmd	Accrued Travel And Entertainment Current AccruedTravelAndEntertainmentCurrent	1371000
CY2022Q2	tcmd	In Transit Inventory Accrued Expense InTransitInventoryAccruedExpense	554000
CY2021Q4	tcmd	In Transit Inventory Accrued Expense InTransitInventoryAccruedExpense	416000
CY2022Q2	tcmd	Accrued Clinical Studies Expenses Current AccruedClinicalStudiesExpensesCurrent	161000
CY2021Q4	tcmd	Accrued Clinical Studies Expenses Current AccruedClinicalStudiesExpensesCurrent	113000
CY2022Q2	tcmd	Accrued Sales And Use Tax AccruedSalesAndUseTax	115000
CY2021Q4	tcmd	Accrued Sales And Use Tax AccruedSalesAndUseTax	106000
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1076000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	744000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5258000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5262000
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4959000
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4841000
CY2022Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	354000
CY2021Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	844000
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	997000
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1456000
CY2022Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	531000
CY2021Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	596000
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1138000
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1180000
CY2022Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4818000
CY2021Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	5117000
CY2022Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4818000
CY2021Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	5117000
CY2022Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2027000
CY2021Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1667000
CY2022Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2027000
CY2021Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1667000
CY2022Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	2791000
CY2021Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	3450000
CY2022Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	2791000
CY2021Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	3450000
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	4818000
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	5117000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2506000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22122000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23354000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	24610000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	25860000
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y7M6D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
	us-gaap	Operating Lease Payments OperatingLeasePayments	1814000
	us-gaap	Operating Lease Payments OperatingLeasePayments	1567000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	41000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	304000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1761000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3425000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3415000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3516000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3615000
CY2022Q2	tcmd	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	13249000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	28981000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4371000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	24610000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2488000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22122000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1000000.0
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	800000
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1900000
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1700000
CY2022Q2	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	41500000
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2900000
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2700000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5100000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5100000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	93832000
	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	15188000
	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	14077000
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1305000
CY2022Q2	us-gaap	Cost Of Goods Sold Sales Type Lease CostOfGoodsSoldSalesTypeLease	2612000
CY2021Q2	us-gaap	Cost Of Goods Sold Sales Type Lease CostOfGoodsSoldSalesTypeLease	2217000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20208000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-961000
CY2022Q2	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	8380000
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2892000
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2658000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5121000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5115000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59645000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51060000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	107623000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	93832000
CY2022Q2	tcmd	Percentage Of Revenue PercentageOfRevenue	1
CY2021Q2	tcmd	Percentage Of Revenue PercentageOfRevenue	1
	tcmd	Percentage Of Revenue PercentageOfRevenue	1
	tcmd	Percentage Of Revenue PercentageOfRevenue	1
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59645000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51060000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	107623000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20024798
	us-gaap	Cost Of Goods Sold Sales Type Lease CostOfGoodsSoldSalesTypeLease	4648000
	us-gaap	Cost Of Goods Sold Sales Type Lease CostOfGoodsSoldSalesTypeLease	4068000
CY2022Q2	us-gaap	Sales Type Lease Selling Profit Loss SalesTypeLeaseSellingProfitLoss	5768000
CY2021Q2	us-gaap	Sales Type Lease Selling Profit Loss SalesTypeLeaseSellingProfitLoss	5213000
	us-gaap	Sales Type Lease Selling Profit Loss SalesTypeLeaseSellingProfitLoss	10540000
	us-gaap	Sales Type Lease Selling Profit Loss SalesTypeLeaseSellingProfitLoss	10009000
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.004
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-14.05
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-20000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1400000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.010
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.771
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3200000
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4640000
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19691156
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19961999
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19618759
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	356121
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20024798
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20047277
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19961999
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19618759
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1546673
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	484477
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1546673
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1286002
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	6200000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	7550000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	13750000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	13800000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4000000.0

Files In Submission

Name	View Source	Status
0001558370-22-011459-index-headers.html	Edgar Link	pending
0001558370-22-011459-index.html	Edgar Link	pending
0001558370-22-011459.txt	Edgar Link	pending
0001558370-22-011459-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tcmd-20220630.xsd	Edgar Link	pending
tcmd-20220630x10q.htm	Edgar Link	pending
tcmd-20220630x10q_htm.xml	Edgar Link	completed
tcmd-20220630xex31d1.htm	Edgar Link	pending
tcmd-20220630xex31d2.htm	Edgar Link	pending
tcmd-20220630xex32d1.htm	Edgar Link	pending
tcmd-20220630xex32d2.htm	Edgar Link	pending
tcmd-20220630_cal.xml	Edgar Link	unprocessable
tcmd-20220630_def.xml	Edgar Link	unprocessable
tcmd-20220630_lab.xml	Edgar Link	unprocessable
tcmd-20220630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TCMD
TACTILE SYSTEMS TECHNOLOGY INC Stock $tcmd

2022 Q3 Form 10-Q Financial Statement

#000155837022011459 Filed on August 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TCMD TACTILE SYSTEMS TECHNOLOGY INC Stock $tcmd

2022 Q3 Form 10-Q Financial Statement

#000155837022011459 Filed on August 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TCMD
TACTILE SYSTEMS TECHNOLOGY INC Stock $tcmd